Regonix ( Regorafenib )

Regorafenib  is an oral multi-kinase inhibitor  involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity.It is used in the therapy of metastatic colorectal cancer , gastrointestinal stromal tumor and  hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib.